Siemann, D W Chaplin, D J Horsman, M R
Published in
Cancer investigation
Vascular targeted therapies (VTTs) are agents that target tumor vasculature and can be classified into two categories: those that inhibit angiogenesis and those that directly interfere with established tumor vasculature. Although both the anti-angiogenic agents (AAs) and the vascular disrupting agents (VDAs) target tumor vasculature, they differ in...
Cvetković, Jovana
Published in
Cancer investigation
One of the most common cancer in females is breasts cancer. This cancer can has high impact on the women including health and social dimensions. One of the most common social dimension is depression caused by breast cancer. Depression can impairs life quality. Depression is one of the symptom among the breast cancer patients. One of the solution is...
Hopp, Elizabeth E Cossette, Stephanie M Kumar, Suresh N Eastwood, Daniel Ramchandran, Ramani Bishop, Erin
Published in
Cancer investigation
Sucrose non-fermenting related kinase (SNRK) is a serine/threonine kinase known to regulate cellular metabolism and adipocyte inflammation. Since alterations in adipocyte metabolism play a role in ovarian cancer metastasis, we investigated the expression of SNRK in benign and malignant human ovarian tissue using immunohistochemistry and qPCR. The n...
D'Alessio, Andrea Marchetti, Marina Tartari, Carmen Julia Russo, Laura Cecchini, Sara Lambregts, Kim W F M di Mauro, Daniela Falanga, Anna
Published in
Cancer investigation
We enrolled 62 consecutive patients with advanced stage cancers and venous thromboembolism (VTE), prospectively followed until 1 year. All patients received 6 month low-molecular-weight heparin (LMWH) therapy. We evaluated thrombin generation (TG) and D-dimer levels at different time points, to determine whether they were sensitive to LMWH and expl...
Lee, Shing M Zhang, Yuan Minasian, Lori M Unger, Joseph M Hershman, Dawn L
Published in
Cancer investigation
In advanced stage patients enrolled in dose-finding trials, it is difficult to assess delayed toxicities because frequently patients discontinue after one or two cycles of treatment. Patients enrolled in phase 2 trials are typically followed longer to assess efficacy. Thus, their data may be useful for evaluating long-term tolerability. We illustra...
Baskar, Ganga Ravi, Mathangi Panda, Jiban Jyoti Khatri, Anjali Dev, Bhawna Santosham, Roy Sathiya, Sekar Babu, Chidambaram Saravana Chauhan, Virander Singh Rayala, Suresh K
...
Published in
Cancer investigation
Lung cancer is the leading cause of cancer deaths and the overall 5-year survival rate is less than 17%. Hyperthermia is an alternative approach for the treatment of lung cancer and is associated with fewer side effects. We employed ironoxide nanoparticles in inducing localized hyperthermia in lung cancer cells using a pulsed electromagnetic field ...
Viñolas, Nuria Garrido, Pilar Isla, Dolores Provencio, Mariano Majem, Margarita Artal, Angel Carcereny, Enric Garcia Campelo, Rosario Lianes, Pilar De La Peñas, Ramon
...
Published in
Cancer investigation
The WORLD07 study characterizes lung cancer in Spanish women. This analysis investigated lung cancer features in never-smoking women. Of 2072 women recruited, 2035 were analyzed. Patient characteristics and demographics were similar for current/former smokers and never smokers. Among never smokers, 38.3% were exposed to passive smoking. Non-small-c...
Polom, Karol Marrelli, Daniele Roviello, Giandomenico Voglino, Costantino Vindigni, Carla Generali, Daniele Roviello, Franco
Published in
Cancer investigation
We analyzed the clinical utility of molecular classification based on anatomical and histological background. The study was conducted on 457 patients treated for gastric cancer with additional information about microsatellite instability status. We divided the patients in three groups of molecular classification based on anatomical and histological...
Published in
Cancer investigation
Wan, Jiayi Chao, Lin Lee, Arier C Chen, Qi
Published in
Cancer investigation
Potential predictive biomarker(s) to respond to chemotherapy in gastric cancer are unclear. Excision repair cross-complementing 1 (ERCC1), a DNA repair enzyme, is associated with clinical outcomes in gastric cancer. Here, we investigated the expression of ERCC1 in gastric cancer with platinum-based chemotherapy after surgery, and the association be...
